Utilization of algal materials for nutraceutical and cosmeceutical applications—what do manufacturers need to know? (original) (raw)

Abstract

Many algal extracts/preparations have been used in nutritional supplements and cosmetics for many decades, notably Dunaliella, Spirulina, Chlorella, Haematococcus, and numerous kelp species. However, the road to acceptance and use of preparations from new species is long, and there are many barriers to overcome. This article outlines what is needed to achieve acceptance from the perspective of a large marketer and manufacturer of a wide variety of consumer products. Real-life applications are used to show the required and desired information that must flow between the raw material supplier and the manufacturer to effectively bring a new material to the marketplace. The viewpoints of many different levels of the organization are considered including: product formulators with their focus on efficacy (of special interest are results from human clinical trials), mechanisms of action and performance of the ingredient in their formulations; quality assurance that looks for consistency and reliability of the ingredient; regulatory personnel that require assurance and documentation that an ingredient is acceptable in markets around the world; and procurement that requires adequacy of supply to fulfill market demand along with competitive pricing and reliable customer service.

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

• Chapman DJ, Gellenbeck KW (1989) An historical perspective of algal biotechnology. In: Cresswell RC, Rees TAV, Shah N (eds) Algal and cyanobacterial technology. Longman, Essex, pp 1–27
  Google Scholar
• FDA (2009) FD&C Act Chapter VI: Cosmetics. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/FDCActChapterVICosmetics/default.htm
• FDA (2011 a) Dietary Supplements. http://www.fda.gov/food/dietarysupplements/default.htm
• FDA (2011 b) New Dietary ingredient notifications and related issues. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/DietarySupplements/ucm257563.htm
• Federal Trade Commission (2011) The Fair Packaging and Labeling Act. http://www.ftc.gov/os/statutes/fplajump.shtm
• Gershwin ME, Belay A (eds) (2008) _Spirulin_a in human nutrition and health. CRC, Boca Raton, p 312
  Google Scholar
• Guerin M, Huntley ME, Olaizola M (2003) Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 21:210–216
  Article PubMed CAS Google Scholar
• Health Canada (2011) Natural health products. http://www.hc-sc.gc.ca/dhpmps/prodnatur/index-eng.php
• Personal Care Products Council (2010) What is INCI? http://www.ctfa.org/science-safety/what-inci

Download references

Author information

Authors and Affiliations

1. Nutrilite Health Institute, Amway Corp, 19600 6th Street, Lakeview, CA, USA, 92567
   Kevin W. Gellenbeck

Authors

1. Kevin W. Gellenbeck
   You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toKevin W. Gellenbeck.

Rights and permissions

About this article

Cite this article

Gellenbeck, K.W. Utilization of algal materials for nutraceutical and cosmeceutical applications—what do manufacturers need to know?.J Appl Phycol 24, 309–313 (2012). https://doi.org/10.1007/s10811-011-9722-z

Download citation

• Received: 30 July 2011
• Revised: 09 September 2011
• Accepted: 09 September 2011
• Published: 29 September 2011
• Issue Date: June 2012
• DOI: https://doi.org/10.1007/s10811-011-9722-z

Keywords